RI passes bill for patient safety committee, error-tracking system
Rhode Island lawmakers have passed legislation that would create a database for voluntary tracking of medical errors by healthcare providers and insurers. The bill, which still requires the governor's signature, would also establish a 14-member care advisory committee to review database findings and create quality improvement strategies. The patient safety group including the database would be a public/private partnership funded by annual fees paid by hospitals, nursing homes, health insurers and reporting agencies. Annual costs for running the group are estimated at just under $600,000. State and federal agencies would not be required to contribute annual fees.
In anticipation of the Centers for Medicare and Medicaid's "never events" policy that goes into effect later this year, Rhode Island joins a growing number of states--including Minnesota, Washington, Oregon, Massachusetts--and carriers including Blue Cross-Blue Shield that have adopted strategies to track and prevent medical errors.
Patient safety organizations also are growing beyond the borders of the United States. This Wednesday, the World Health Organization will formally launch its own a patient safety strategy designed to prevent medical errors.
For more:
- read the Modern Healthcare article
- glance at WHO initiative information
Comments
R.I. like every other state Patient Safety Bills or acts is in name only. Voluntary tracking of medical errors by healthcare providers and insurers does not constitute a safety program. Extensive use of many combined medications are causing serious dangerous harmful conditions and fatalities. The Medical Profession, Healtcare Industries, Hospitials and Phareceuticals must begin ethical safety programs. Patients must be treated as an indivual,not as a statistic.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




